Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation

PHASE4CompletedINTERVENTIONAL
Enrollment

1,067

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

May 24, 2021

Study Completion Date

June 21, 2021

Conditions
Acute Respiratory FailureIntubation ComplicationHypotension on Induction
Interventions
DRUG

Fluid Bolus

500 milliliters of an intravenous crystalloid solution of the operator's choosing

OTHER

No Fluid Bolus

No additional intravenous crystalloid administration initiated between randomization and two minutes after completion of endotracheal intubation

Trial Locations (11)

27157

Wake Forest Baptist Medical Center, Winston-Salem

35233

University of Alabama at Birmingham, Birmingham

37209

Vanderbilt University Medical Center, Nashville

39216

University of Mississippi Medical Center, Jackson

55415

Hennepin County Medical Center, Minneapolis

70112

Louisiana State University School of Medicine, New Orleans

76508

Baylor Scott & White Medical Center - Temple, Temple

97239

Oregon Health & Science University, Portland

98195

University of Washington, Seattle

Louisiana

"Ochsner Medical Center , Ochsner Health System"

01805

Lahey Hospital & Medical Center, Burlington

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT03787732 - Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation | Biotech Hunter | Biotech Hunter